Predictive Oncology Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Predictive Oncology Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2011 to Q3 2024.
  • Predictive Oncology Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 6.4M shares, a 58.7% increase year-over-year.
  • Predictive Oncology Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 4.01M shares, a 8.92% increase from 2022.
  • Predictive Oncology Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 3.69M shares, a 93.3% decline from 2021.
  • Predictive Oncology Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 54.9M shares, a 359% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 6.4M +2.36M +58.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 4.66M +668K +16.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 4.06M +94.8K +2.39% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 4.01M +329K +8.92% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 4.03M +112K +2.86% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 4M +407K +11.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 3.97M +676K +20.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 3.69M -51.2M -93.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 3.92M -61.5M -94% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 3.59M -48M -93% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 3.29M -33.2M -91% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 54.9M +42.9M +359% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-21
Q3 2021 65.4M +50.4M +335% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 51.6M +41.7M +424% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 36.5M +31.6M +647% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 12M +9.08M +316% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 15M +11.9M +378% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 9.84M +3.83M +63.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 4.89M +3.31M +211% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 2.87M +1.59M +124% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-15
Q3 2019 3.15M +1.82M +137% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 6.01M -5.87M -49.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 1.57M -9.81M -86.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-08
Q4 2018 1.28M Oct 1, 2018 Dec 31, 2018 10-K 2020-04-01
Q3 2018 1.33M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-15
Q2 2018 11.9M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-19
Q1 2018 11.4M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2013 152M +82.4M +118% Oct 1, 2013 Dec 31, 2013 10-K 2014-03-27
Q3 2013 137M +57.3M +72.1% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-14
Q2 2013 121M +66.6M +122% Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-14
Q1 2013 108M +75.2M +230% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-15
Q4 2012 69.6M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-27
Q3 2012 79.5M +52.2M +192% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 54.7M +32M +141% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 32.7M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q3 2011 27.2M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-15
Q2 2011 22.7M Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.